Report overview
The global Arginine Hydrochloride Injection market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Intramuscular Injection Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Arginine Hydrochloride Injection include Pfizer, B.Braun, Huinan Changlong-Bio, Chongqing Yaoyou Pharmaceutical, Shanghai Xinyi Jinzhu Pharmaceutical, Jiangsu Kanion Pharmaceutical, Wuhan Fuxing Biological Pharmaceutical, Wuhan Jiu'an Pharmaceutical and Guangdong Leiyunshang Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Arginine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arginine Hydrochloride Injection. This report contains market size and forecasts of Arginine Hydrochloride Injection in global, including the following market information:
Global Arginine Hydrochloride Injection Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Arginine Hydrochloride Injection Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Arginine Hydrochloride Injection companies in 2023 (%)
We surveyed the Arginine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Arginine Hydrochloride Injection Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Arginine Hydrochloride Injection Market Segment Percentages, by Type, 2023 (%)
Intramuscular Injection
Intravenous Drip
Global Arginine Hydrochloride Injection Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Arginine Hydrochloride Injection Market Segment Percentages, by Application, 2023 (%)
Hepatic Encephalopathy
Psychiatric Symptoms Due to Elevated Blood Ammonia
Other
Global Arginine Hydrochloride Injection Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Arginine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Arginine Hydrochloride Injection revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Arginine Hydrochloride Injection revenues share in global market, 2023 (%)
Key companies Arginine Hydrochloride Injection sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Arginine Hydrochloride Injection sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
B.Braun
Huinan Changlong-Bio
Chongqing Yaoyou Pharmaceutical
Shanghai Xinyi Jinzhu Pharmaceutical
Jiangsu Kanion Pharmaceutical
Wuhan Fuxing Biological Pharmaceutical
Wuhan Jiu'an Pharmaceutical
Guangdong Leiyunshang Pharmaceutical
KINGYOR
Beijing Science Sun
Outline of Major Chapters:
Chapter 1: Introduces the definition of Arginine Hydrochloride Injection, market overview.
Chapter 2: Global Arginine Hydrochloride Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Arginine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Arginine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Arginine Hydrochloride Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
